Top 100 alternative sites to imv-inc.com
-
imv-technologies.fr
-
imv-technologies.in
-
imvinfo.com
-
hcwevents.com
-
medicago.com
-
acimmune.com
-
humanvaccinesproject.org
-
adaptimmune.com
-
etherna.be
-
abcuro.com
-
i-mabbiopharma.com
-
vaccibody.com
-
ocugen.com
-
adicetbio.com
-
mtem.com
-
bellicum.com
-
verovaccines.org
-
cgoncology.com
-
firstwavebio.com
-
hookipapharma.com
-
khondrion.com
-
replimune.com
-
formatherapeutics.com
-
cuebiopharma.com
-
cellectis.com
-
pdsbiotech.com
-
abcentra.com
-
beyondair.net
-
oysterpointrx.com
-
tvaxbiomedical.com
-
aptose.com
-
humanigen.com
-
zymeworks.com
-
chinooktx.com
-
cariboubio.com
-
altimmune.com
-
ocuphire.com
-
erc-immunotherapy.com
-
kezarlifesciences.com
-
marizyme.com
-
tessacell.com
-
celularity.com
-
arcturusrx.com
-
emmausmedical.com
-
eurekatherapeutics.com
-
repertoire.com
-
arvinas.com
-
pharnext.com
-
radiomedix.com
-
connectbiopharm.com
-
nerxbiosciences.com
-
translate.bio
-
delpor.com
-
tricida.com
-
rebiotix.com
-
byondis.com
-
canprevent.com
-
glycadia.com
-
rapt.com
-
cardiffoncology.com
-
oculis.com
-
g1therapeutics.com
-
lc4consulting.com
-
orphomed.com
-
marinuspharma.com
-
madrigalpharma.com
-
interna-technologies.com
-
eledon.com
-
cellestia.com
-
sola-bio.com
-
algiax.com
-
millenniumci.com
-
processapharmaceuticals.com
-
sonnetbio.com
-
ltbridge.com
-
diamedica.com
-
bioxceltherapeutics.com
-
newresi.com
-
brunswick.com
-
texaspacific.com
-
basices.com
-
bristowgroup.com
-
div.energy
-
milestonescientific.com
-
macysinc.com
-
fortressbiotech.com
-
wtoffshore.com
-
freedomholdingcorp.com
-
trevena.com
-
heliostechnologies.com
-
northernoil.com
-
clsholdingsinc.com
-
investors.coca-colacompany.com
-
gladstonecommercial.com
-
matw.com
-
vfc.com
-
shpxtqd.com
-
k3005.com
-
interpace.com
-
opko.com
Accueil - IMV Technologies France
Home Page - IMV Inde
Market Reports on Medical Imaging & Clinical Diagnostic Markets
Recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets.
HCW Events
HC Wainwright Annual Global Investor Conference
Developing novel vaccines and therapeutic proteins | Medicago
Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.
AC Immune
AC Immune biopharmaceutical company developing innovative therapeutics with \'best in class\' potential against Alzheimer´s Disease and other conformational diseases along three axes: vaccines, antibodies and small molecules.
Human Vaccines Project
To accelerate the development of vaccines and immunotherapies against major global infectious diseases and cancers by decoding the human immune system.
Adaptimmune Therapeutics plc
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Home | mRNA immunotherapies | eTheRNA immunotherapies NV
eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases.
Home - Abcuro
Development of immunotherapies for autoimmune diseases and cancer Read more about our approach in Fierce Biotech KLRG1 – A Compelling Clinical Target in Immune Modulation Abcuro is a clinical stage biotechnology company developing first-in-class immunotherapies for autoimmune diseases and cancer … Read More
Author: Abcuro
I-Mab Biopharma | Bringing Transformational Medicines to Patients Through Innovation
I-Mab is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class and best-in-class biologics to treat cancers and autoimmune diseases.
Home - Vaccibody.com
Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies
Ocugen, Inc. – Pursuing Innovative Ocular Biotherapeutics
Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
Adicet Bio | Gamma Delta T cells
Adicet Bio, a pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.
Molecular Templates, Inc. (MTEM)
Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
Home - Bellicum Pharmaceuticals, Inc. : Bellicum Pharmaceuticals, Inc.
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
VEROVACCiNES GmbH develops novel vaccines for animal health
VEROVACCiNES GmbH is an innovative biopharmaceutical company and uses a proprietary technology to develop a novel class of vaccines. Advantages of the vaccines are thermostability, very cost-effective manufacture and easy combination.
Oncolytic immunotherapy | CG0070 | CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.
Home - First Wave BioPharma, Inc.
First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
Other sites like imv-inc com
Hookipa Pharma - Supercharging Immunotherapy
Hookipa Pharma Inc. is a clinical stage company developing products to prevent and cure infectious diseases and cancer. With this goal in mind, we created unique and cutting-edge technologies to reprogram and stimulate the immune system.
Home - Khondrion
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
Home - Replimune
Replimune is creating a new class of oncolytic immunotherapy designed to ignite a powerful immune response to treat cancer and vaccinate against future relapse.
Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Immune Responses, On Cue - Cue Biopharma
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) is designed to harness the body’s intrinsic […]
Home | Cellectis
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer
PDS Biotech - Home
PDS Biotech is committed to developing novel and effective therapies based on the Versamune® platform to save and improve the lives of cancer patients worldwide. We are also committed to developing safer and more powerful infectious disease vaccines to prevent against selected deadly infectious diseases.
Abcentra - Therapeutics
Abcentra is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for cardiovascular and inflammatory diseases.
Beyond Air Inc. (XAIR)
Beyond Air is a clinical-stage medical device and biopharmaceutical company using nitric oxide to treat respiratory and other diseases.
Oyster Point Pharma - Therapies to Address Ophthalmic Disease
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease.
TVAX Biomedical, Inc.
TVAX Biomedical, Inc. is a biotechnology company currently performing phase II clinical trials to test a unique natural cancer immunotherapy as a treatment for brain cancer.
Aptose Biosciences Inc.
Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers.
Humanigen, Inc.
We are a clinical stage biopharmaceutical company, developing our immunology and immuno-oncology portfolio of monoclonal antibodies.
Zymeworks
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
Chinook Therapeutics | Atrasentan
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Altimmune a clinical stage biopharmaceutical company
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Ocuphire Pharma, Inc. (OCUP)
Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company developing and commercializing therapies for the treatment of eye disorders.
ERC - Epitopoietic Research Corporation
ERC is a clinical stage emerging Bio-pharmaceutical Company developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with Glioblastoma multiforme (GBM) the most deadliest form of brain cancer using its patented Gliovac/ERC1671 vaccine.
Author: Www Erc Eu
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences is a clinical-stage biotechnology company committed to revolutionizing treatments for patients with autoimmune diseases and cancer.
What else imv-inc.com alternative websites
Marizyme, Inc. | Monetizing Life Science Assets
Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on developing and commercializing proprietary pharmaceuticals that improve the treatment of cancer and other life-threatening illnesses.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
Celularity Inc. (NASDAQ:CELU)
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Author: Celularity Inc
Arcturus Therapeutics
Arcturus Therapeutics is a clinical-stage messenger RNA medicines company focused on development and distribution of therapeutics for rare diseases & vaccines.
Emmaus Medical, Inc.
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.
Eureka Therapeutics | ARTEMIS™ | E-ALPHA® | T-cell therapies
Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
Home • Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
Home • Arvinas
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
Pharnext - Pharnext
Pharnext is an advanced clinical-stage biopharmaceutical company developing novel first-in-class therapies for orphan and common diseases with high unmet medical needs, leveraging our artificial intelligence (AI)-based PLEOTHERAPY™ platform.
RadioMedix, Inc
RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. The company is developing radiopharmaceuticals for PET imaging and therapeutic (alpha and beta-labeled) radiopharmaceuticals.
Connect Biopharma - Next-Generation Therapeutics for T Cell-Driven Inflammatory Diseases
Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
NĒRx BioSciences Inc | 212 W 10th Street, Indianapolis, IN 46202
NĒRx BioSciences Inc is a company dedicated to the discovery and development of targeted therapeutics for cancer. Formed in 2009, we specialize in the discovery and early development of novel biopharmaceutical compounds.
mRNA Therapeutics for Genetic Disease | Translate Bio
Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat and prevent diseases caused by protein or gene dysfunction.
Delpor.com – Breakthrough Discoveries for a Better Life
News View All Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.
Author: Delpor Admin
Tricida | Working to Turn the Tide on Metabolic Acidosis
Tricida, Inc., is a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of non-absorbed therapies. Tricida’s lead investigational **** candidate, TRC101, represents a first-in-class approach to the treatment of metabolic acidosis, a common complication of chronic kidney disease (CKD) that can result in increased mortality, accelerated progression of kidney disease, progressive muscle breakdown and exacerbation of bone disease.
Microbiota Restoration Therapy™ for Gastrointestinal Diseases | Rebiotix Inc.
A clinical stage microbiome company developing microbiota restoration therapies for the treatment of gastrointestinal diseases from gut dysbiosis.
Byondis | Creating Precision Medicines
We are a clinical stage biopharmaceutical research and development company with around 400 staff, including highly educated scientists and skilled technicians who share the same goal: To create safe and effective precision medicines targeting intractable cancers and autoimmune diseases, improving the standard of care for patients.
Home Page - Cancer Prevention
Cancer Prevention Pharmaceuticals is a clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases. CPP’s innovative technology addresses polyamine metabolism, immune regulation and inflammation to reduce cancer risk and impact other diseases. These … Continue reading →
Glycadia Pharmaceuticals – Glycadia Pharmaceuticals
Commitment to Discovery Glycadia is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular and related diseases that result from diabetes. Learn More Focus and Market The current approach to
Author: Gp J
Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. Our cutting-edge science is fully focused on developing **** therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Join us …
Other websites similar as imv-inc.com
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Oculis |
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and the lives of patients worldwide.
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
Business Development Competencies to Maximize the Value of Your Pipeline and In-Licensing Programs - LC4 Consulting GmbH
LC4 Consulting is a boutique agency fully focusing on supporting teams with new products in early development stage, including business development programs. We are offering a breath of experience in a wide range of immunotherapies, auto-immune compounds and biologics in the cancer settings, e.g. monoclonal antibodies, Antibody **** Conjugates (ADC), and cell based cancer vaccines.
OrphoMed Inc. | Gastrointestinal Disorders | Dimer Therapeutics Platform
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
Home - Marinus Pharmaceuticals
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders.
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.
Author: Dr Rebecca Taub; M D
Breakthrough miRNA therapeutics tackling cancer - InteRNA Technologies
A Dutch clinical-stage biotech company InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation **** delivery
Eledon Pharmaceuticals: Developing precision therapeutics that target the CD40 Ligand pathway
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing **** or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
Cellestia, modulating gene expression
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-**** resistant cancers.
Home -
SOLA Biosciences (Greater Boston, MA) is a pre-clinical-stage biopharmaceutical company focusing on developing transformative gene therapies to treat protein misfolding diseases. SOLA developed a proprietary “JUMP70 (J-domain Upholding Misfolding-Protein for Hsp70 Chaperone)” technology platform designed to harness the power of a patient’s own chaperones to repair disease-causing proteins. SOLA is currently developing eight (8) pipeline … Continue reading "Home"
Home | Algiax Pharmaceuticals GmbH
News – Events About Us Algiax Pharmaceuticals is a clinical-stage biotechnology company established in 2011. It is dedicated to the discovery and development of innovative products to treat diseases with a high unmet medical need. Algiax’ lead candidate AP-325 is a small-molecule GABAA receptor modulator in clinical development as a therapy for neuropathic pain. Next […]
Millennium Consultants Inc. - Custom Software Development Company in Princeton
Millennium Consultants, Inc. is a custom software development company in Princeton, New Jersey. Millennium provides world-class custom software development services explicitly designed for organizations to prosper in the digital age.
Author: Millennium
Some websites with similar theme to imv-inc.com include:
Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals is committed to developing **** products aimed at improving the quality of life for patients with unmet medical needs.
Sonnet BioTherapeutics, Inc. (SONN)
Sonnet BioTherapeutics is taking the fight directly to cancer using its proprietary FHAB™ technology to empower innovative targeted biologic drugs.
Lightbridge Corporation (LTBR)
Lightbridge Corporation is a nuclear fuel technology development company focused on addressing the world’s climate and energy needs.
DiaMedica Therapeutics, Inc. (DMAC)
DiaMedica Therapeutics is a biopharmaceutical company that specializes in creating synthetic proteins to treat a variety of conditions.
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics is developing high value therapeutics in neuroscience and immuno-oncology utilizing a novel artificial intelligence platform.
New Residential Investment Corp. (NRZ)
New Residential is a publicly traded mortgage real estate investment trust with a diversified portfolio and a strong track record of performance.
Brunswick Corporation
Brunswick Corporation, a world-class leader in the marine industry, turns innovation into reality via renowned marine brands.
More other alternatives for imv-inc com
Texas Pacific Land Corporation (TPL)
Texas Pacific Land Trust is one of the largest landowners in the State of Texas with approximately 900,000 acres of land in West Texas.
Basic Energy Services, Inc.
Basic Energy Services offers a diverse number of services to oil drilling and natural gas producing companies in the U.S.
Bristow Group Inc. (VTOL)
Bristow provides safe, reliable and efficient helicopter services for offshore oil and gas transportation, SAR and government and civil organizations.
Diversified Energy Company PLC
Milestone Scientific, Inc: Next Generation Medical Solutions :: Milestone Scientific, Inc. (MLSS)
Milestone Scientific, Inc. (MLSS) is a pioneer of next generation medical equipment and solutions. Find corporate, investor, product news, and more on our site.
Macy's, Inc.
Macy’s, Inc. is one of the nation’s premier omnichannel retailers. Headquartered in New York City, the company comprises three retail brands: Macy’s, Bloomingdale’s and Bluemercury. With a robust e-commerce business, rich mobile experience and a national stores footprint, our customers can shop the way they live — anytime and through any channel.
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company that was ranked in Deloitte’s 2019 and 2020 Technology Fast 500™, annual rankings of the fastest-growing North American companies in the technology,…
W&T Offshore, Inc.
W&T Offshore, Inc. is an independent oil and natural gas producer, exploring, developing, and acquiring oil and natural gas in the Gulf of Mexico.
Freedom Holding Corp. (FRHC)
Freedom Holding is a US-based corporation that owns several operating subsidiaries that engage in the securities industry in Central Asia.
Trevena, Inc. (TRVN)
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions.
Helios Technologies (HLIO)
Helios Technologies (formerly Sun Hydraulics Corporation) is a global industrial technology leader that develops and manufactures hydraulic and electronic control solutions for diverse markets.
Northern Oil and Gas, Inc. (NOG)
Northern Oil and Gas, Inc. (NYSE MKT: NOG) is the leading non-operated working interest franchise in the premier shale basins across the United States. The foundation of the Company's success is the long-term relationships it has built in basin…
CLS Holdings USA, Inc. (CLSH)
Cannabis Life Sciences is both a cannabis producer and retailer offering a wide variety of products through its brands, Oasis and City Trees.
Investor Relations :: The Coca-Cola Company (KO)
Gladstone Commercial Corporation (GOOD)
Matthews International Corporation (MATW)
Matthews International Corporation is a global provider of brand solutions, memorialization products and industrial technologies.
VF Corporation (VFC)
VF Corporation outfits consumers around the world with its diverse portfolio of iconic outdoor and activity-based lifestyle and workwear brands.
btcc经贸环球交易所_比特币global交易软件_BTCC官网
Texas Pacific Land Trust is one of the largest landowners in the State of Texas with approximately 900,000 acres of land in West Texas.
幸运飞艇最新开奖结果查询-实时开奖直播视频-新版飞鹰计划 Norwegian Cruise Line Holdings Ltd. (NCLH)
Interpace Biosciences, Inc. (IDXG)
Interpace Diagnostics Group provides clinically useful molecular and related first line diagnostic tests for evaluating risk of cancer.
OPKO Health, Inc. (OPK)
OPKO Health is a diverse healthcare company focused on improving patient lives.
